Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.

By Florian Zink, S. Stacey, G. Norddahl, M. Frigge, O. Magnusson, I. Jónsdóttir, Thorgeir E. Thorgeirsson, A. Sigurdsson, S. A. Gudjonsson, J. Gudmundsson and 12 more. Blood, 2017

713 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics, Hematology

View Paper: https://www.semanticscholar.org/paper/99f6d56648123e04c14d6b20f666d989dd70267a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. K. Walsh
2. Benjamin L. Ebert
3. Siddhartha Jaiswal

In Genetics

1. Benjamin L. Ebert
2. Siddhartha Jaiswal

In Hematology

1. Benjamin L. Ebert
2. Siddhartha Jaiswal

Citations in the corpus

• Clonal hematopoiesis in human aging and disease (2019, positive): “Several studies have found that CHIP is associated with a 30 to 40% increased mortality risk (28, 29, 38).”
• Tet2-mediated Clonal Hematopoiesis Accelerates Heart Failure through a Mechanism Involving the IL-1β/NLRP3 Inflammasome (2018, background): “Recent longitudinal studies have reported that detectable clonal hematopoiesis in non-symptomatic individuals is associated with all-cause mortality (6,7,9).”